13F HOLDINGS REPORT
Logos Global Management LP
Quarter ended Q4 2023 · Filed November 14, 2023 · Accession 0001172661-23-003853
Total Value
$749.5M
Positions
56
Other Managers
0
Confidential Omitted
No
Holdings (56)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | IMMUNOVANT INC | IMVT | 1,600,000 | $61.4M | 8.19% |
| 2 | IDEAYA BIOSCIENCES INC | IDYA | 2,250,000 | $60.7M | 8.10% |
| 3 | OLEMA PHARMACEUTICALS INC | OLMA | 3,743,875 | $46.2M | 6.17% |
| 4 | ROCKET PHARMACEUTICALS INC | RCKTW | 1,975,000 | $40.5M | 5.40% |
| 5 | CYTOKINETICS INC | CYTK | 1,250,000 | $36.8M | 4.91% |
| 6 | AKERO THERAPEUTICS INC | 00973Y108 | 600,000 | $30.3M | 4.05% |
| 7 | APELLIS PHARMACEUTICALS INC | APLS | 750,000 | $28.5M | 3.81% |
| 8 | STRUCTURE THERAPEUTICS INC | GPCR | 500,000 | $25.2M | 3.36% |
| 9 | APELLIS PHARMACEUTICALS INC | APLS | 650,000 | $24.7M | 3.30% |
| 10 | SAREPTA THERAPEUTICS INC | SRPT | 200,000 | $24.2M | 3.23% |
| 11 | IMMUNOCORE HLDGS PLC | IMCR | 450,000 | $23.4M | 3.12% |
| 12 | ICOSAVAX INC | 45114M109 | 2,765,741 | $21.4M | 2.86% |
| 13 | DYNE THERAPEUTICS INC | DYN | 2,180,000 | $19.5M | 2.61% |
| 14 | KARUNA THERAPEUTICS INC | 48576A100 | 115,000 | $19.4M | 2.59% |
| 15 | NEUROCRINE BIOSCIENCES INC | NBIX | 150,000 | $16.9M | 2.25% |
| 16 | VIRIDIAN THERAPEUTICS INC | VRDN | 1,050,000 | $16.1M | 2.15% |
| 17 | XENON PHARMACEUTICALS INC | XENE | 450,000 | $15.4M | 2.05% |
| 18 | CEREVEL THERAPEUTICS HLDNG I | 15678U128 | 700,000 | $15.3M | 2.04% |
| 19 | ROIVANT SCIENCES LTD | ROIV | 1,200,000 | $14.0M | 1.87% |
| 20 | BRIDGEBIO PHARMA INC | BBIO | 500,000 | $13.2M | 1.76% |
| 21 | MIRATI THERAPEUTICS INC | 60468T105 | 300,000 | $13.1M | 1.74% |
| 22 | ANNEXON INC | ANNX | 5,300,000 | $12.5M | 1.67% |
| 23 | IMMATICS N.V | IMTX | 1,050,000 | $12.2M | 1.62% |
| 24 | DESIGN THERAPEUTICS INC | DSGN | 5,032,501 | $11.9M | 1.58% |
| 25 | ALLAKOS INC | 01671P100 | 4,650,000 | $10.6M | 1.41% |
| 26 | BRIDGEBIO PHARMA INC | BBIO | 400,000 | $10.5M | 1.41% |
| 27 | RHYTHM PHARMACEUTICALS INC | RYTM | 400,000 | $9.2M | 1.22% |
| 28 | KALVISTA PHARMACEUTICALS INC | KALV | 900,000 | $8.7M | 1.16% |
| 29 | VENTYX BIOSCIENCES INC | 92332V107 | 225,000 | $7.8M | 1.04% |
| 30 | CRINETICS PHARMACEUTICALS IN | CRNX | 250,000 | $7.4M | 0.99% |
| 31 | GRACELL BIOTECHNOLOGIES INC | 38406L103 | 2,525,000 | $7.3M | 0.97% |
| 32 | COMPASS PATHWAYS PLC | CMPS | 950,000 | $7.0M | 0.94% |
| 33 | REVOLUTION MEDICINES INC | RVMDW | 250,000 | $6.9M | 0.92% |
| 34 | MORPHOSYS AG | 617760202 | 950,000 | $6.4M | 0.85% |
| 35 | REPARE THERAPEUTICS INC | 760273102 | 500,000 | $6.0M | 0.81% |
| 36 | GERON CORP | GERN | 2,750,000 | $5.8M | 0.78% |
| 37 | MERUS N V | N5749R100 | 245,000 | $5.8M | 0.77% |
| 38 | ALX ONCOLOGY HLDGS INC | ALXO | 1,000,000 | $4.8M | 0.64% |
| 39 | 89BIO INC | 282559103 | 310,000 | $4.8M | 0.64% |
| 40 | IOVANCE BIOTHERAPEUTICS INC | IOVA | 1,000,000 | $4.5M | 0.61% |
| 41 | DELCATH SYS INC | DCTH | 1,044,444 | $4.2M | 0.56% |
| 42 | ENLIVEN THERAPEUTICS INC | ELVN | 307,076 | $4.2M | 0.56% |
| 43 | ASTRIA THERAPEUTICS INC | 04635X102 | 544,960 | $4.1M | 0.54% |
| 44 | SOLENO THERAPEUTICS INC | SLNO | 125,000 | $3.7M | 0.49% |
| 45 | REPARE THERAPEUTICS INC | 760273102 | 300,000 | $3.6M | 0.48% |
| 46 | VERVE THERAPEUTICS INC | 92539P101 | 215,000 | $2.9M | 0.38% |
| 47 | ZURA BIO LTD | ZURA | 424,000 | $2.8M | 0.37% |
| 48 | AEGLEA BIOTHERAPEUTICS INC | SYRE | 210,000 | $2.6M | 0.34% |
| 49 | AMBRX BIOPHARMA INC | 02290A102 | 115,000 | $1.3M | 0.18% |
| 50 | VIGIL NEUROSCIENCE INC | 92673K108 | 188,390 | $1.0M | 0.14% |
| 51 | IO BIOTECH INC | IOBT | 493,827 | $696,296 | 0.09% |
| 52 | IMMUNIC INC | IMUX | 421,184 | $619,140 | 0.08% |
| 53 | LEAP THERAPEUTICS INC | CYPH | 354,266 | $488,887 | 0.07% |
| 54 | TYRA BIOSCIENCES INC | TYRA | 31,872 | $438,877 | 0.06% |
| 55 | LIANBIO | LIANY | 280,000 | $417,200 | 0.06% |
| 56 | NUVATION BIO INC | NUVB | 66,666 | $6,667 | 0.00% |